iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Shares Bought by Axxcess Wealth Management LLC

Axxcess Wealth Management LLC boosted its holdings in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 47.3% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 5,001 shares of the company’s stock after buying an additional 1,607 shares during the quarter. Axxcess Wealth Management LLC’s holdings in iShares U.S. Pharmaceuticals ETF were worth $329,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the business. Thrivent Financial for Lutherans grew its holdings in iShares U.S. Pharmaceuticals ETF by 23.6% during the third quarter. Thrivent Financial for Lutherans now owns 32,509 shares of the company’s stock worth $2,295,000 after acquiring an additional 6,214 shares during the period. FMR LLC grew its holdings in iShares U.S. Pharmaceuticals ETF by 10.9% during the third quarter. FMR LLC now owns 13,581 shares of the company’s stock worth $959,000 after acquiring an additional 1,338 shares during the period. Flow Traders U.S. LLC acquired a new stake in iShares U.S. Pharmaceuticals ETF during the third quarter worth about $839,000. Pinnacle Family Advisors LLC grew its holdings in iShares U.S. Pharmaceuticals ETF by 75.8% during the third quarter. Pinnacle Family Advisors LLC now owns 11,595 shares of the company’s stock worth $819,000 after acquiring an additional 5,000 shares during the period. Finally, Jane Street Group LLC boosted its position in iShares U.S. Pharmaceuticals ETF by 5.5% during the third quarter. Jane Street Group LLC now owns 11,846 shares of the company’s stock worth $836,000 after purchasing an additional 616 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Trading Down 0.3 %

Shares of IHE stock opened at $70.21 on Friday. The company has a market capitalization of $617.85 million, a P/E ratio of 25.04 and a beta of 0.63. The business’s 50 day moving average is $69.88 and its two-hundred day moving average is $69.33. iShares U.S. Pharmaceuticals ETF has a 12-month low of $62.68 and a 12-month high of $73.28.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.